Saturday, December 29, 2012 1:14:08 PM
I'm certain he won't sell those. :)
http://www.faqs.org/sec-filings/120820/Amarantus-BioSciences-Inc_10-Q/ex3_1.htm
Does anyone know what the conversion is on the series "A" preferred shares?
He gives the current shareholders a "poison bill" which will stop speculative momentum while he's looking at 125,000,000 shares to be issued to himself "down the road".
Gerald has the shareholder's best interest at heart.
p.s. Now you know why the company needs a billion shares authorized.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM